bullish
Jacobio Pharma: Focus on Novel Targets
353 Views21 Oct 2020 02:00
An in-depth overview of the proposed listing of Jacobio Pharmaceuticals using a framework that touches on the science, market opportunity, intellectual property, management and VCs, and valuation.
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 10-minute read)
Discussions
(Paid Plans Only)
Kemp Dolliver, CFA
Founder
Price Chart(Sign Up to Access)
- Antengene: We Like the Deal10 Nov 2020
- Antengene: Gunning To Move Up in Line06 Nov 2020
- What HKEX Biotech "Step-Ups" Can Tell Us24 Oct 2020
- Jacobio (加科思药业) Pre-IPO: Right Team but Long Time to Market14 Oct 2020
x